My Money, My Choices

MeDirect provides the tools you need to put your money to work – safely, simply and on your own terms.

Mobile and Card

Commission-Free Buys: Open the door to Investing with MeDirect today!

A platform where you are in control of your money

invest for your future

Invest for your Future

Buy mutual funds  online at low fees

Different securities to choose from

contact us header image

Save Smartly

No hidden account or maintenance fees

Manage different currencies

Your debit card

Your Debit Card

Free card and transfers

Multiple currency account facility

get your dream home

Get your Dream Home

Faster than market turnaround times

No processing fees

medirect-applepay

Make contactless payments with Apple Pay

Add your MeDirect Debit Card to Apple Wallet and enable contactless and online purchases via your smartphone or smartwatch.

apple pay
Previous slide
Next slide
Previous slide
Next slide
+ 0
Customers using our service
+€ 0 Billion
Trusted with us
0 /5
Apple App Store Rating
4.6/5

My app, my choices.

The MeDirect Mobile App, giving you access to your finances anywhere, anytime. A user-friendly design makes it easy to manage your money. 

What others say about us

We partner with the best in the industry

News & Updates

Blue Whale Update: Seven Years – Investing Over the Full Market Cycle

In this article, Stephen Yiu reflects on the Blue Whale Growth Strategy’s impressive performance over the past seven years, navigating a full market cycle and global uncertainties. Looking ahead, the strategy remains focused on identifying high-quality businesses poised for growth, with the aim of delivering consistent outperformance for investors in the future.

Our conviction in global stocks

BlackRock Commentary: Our conviction in global stocks

China’s stock surge highlights the benefit of targeting global opportunities with clear catalysts, while BlackRock maintains a U.S. equity overweight on expanding AI themes, favors Japanese stocks for their strong outlook, holds a less confident overweight in UK stocks, and upgrades UK gilts with expectations for deeper policy rate cuts.

Bank of Valletta Bond Issue 2024

Bank of Valletta plc – New Bond Issue

MeDirect is accepting applications from anyone interested in applying for the Bank of Valletta plc 5% unsecured subordinated bonds, maturing between 2029 and 2034

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 


Sign up and open your account for free, within minutes.

MeDirect_Multi-Devices-cards
Subscribe to our newsletter

Keep up to date

Just the news and tips you need to manage your accounts with confidence… but only if you want to.

All investment decisions must be based only on the legal offering documents. The legal offering documents (Key Information Document (KID), Prospectus/Base Prospectus and annual and semi-annual reports) are available free of charge at this website and/or from the issuer’s website. If you invest you may lose some or all of the money you invest. The price of investments and any income can go down as well as up.

Subscribe to our Newsletter

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.

Subscribed to MeDirect Newsletter